Department of Otorhinolaryngology, Head and Neck Surgery, Hospital Mutterhaus der Borromäerinnen, Academic Teaching Hospital of University of Mainz, Trier, Germany.
Eur Arch Otorhinolaryngol. 2012 Mar;269(3):853-60. doi: 10.1007/s00405-011-1742-4. Epub 2011 Sep 8.
Aim of the study is to evaluate the effects of medical and surgical treatment in divers with paranasal sinus barotrauma (PSB) secondary to chronic rhinosinusitis (CRS). In this retrospective, cross-sectional, descriptive study 40 adult divers with CRS were included. Treatment of divers implied a 5-day course of a systemic steroid and a 6-week course of saline nasal irrigations and topical nasal steroid with mometasone in maximal dosage. If symptoms persisted, functional endoscopic sinus surgery (FESS) was performed. Questionnaires included the Sinonasal Outcome Test-20 German Adapted Version (SNOT-20 GAV), dive-related questions (DRQ) and general questions. Questionnaires were completed retrospectively by recalling the symptoms before and after therapy. Forty of 82 divers completed the questionnaires. Mean follow-up was 42 months (range 13-95 months). There was a statistically significant improvement of the Total score (TS) and of every subscore, except the General Quality of Life score, in the SNOT-20 GAV as well as of the TS in the DRQ. Before treatment, divers who required surgery reported significantly more symptoms than divers who were treated conservatively. Post treatment there were no significant differences between the medical and surgical group. Overall, 35 divers could resume diving after therapy even though PSB still occurred but without complications. Divers with sinus problems can successfully be managed medically and if conservative treatment fails, FESS shows a statistically significant improvement of symptoms and no serious long-term hazards for diving.
研究目的在于评估患有慢性鼻-鼻窦炎(CRS)的潜水员因鼻窦气压伤(PSB)而接受医学和手术治疗的效果。在这项回顾性、横断面、描述性研究中,纳入了 40 名患有 CRS 的成年潜水员。对潜水员的治疗包括 5 天疗程的全身类固醇和 6 周疗程的盐水鼻腔冲洗以及莫米松的局部鼻腔类固醇治疗,最大剂量。如果症状持续存在,则进行功能性内窥镜鼻窦手术(FESS)。调查问卷包括鼻-鼻窦结局测试-20 德语修订版(SNOT-20 GAV)、与潜水相关的问题(DRQ)和一般问题。调查问卷通过回忆治疗前后的症状进行回顾性填写。82 名潜水员中有 40 名完成了调查问卷。平均随访时间为 42 个月(范围 13-95 个月)。SNOT-20 GAV 的总评分(TS)和每个子评分均有统计学显著改善,除一般生活质量评分外,DRQ 的 TS 也有统计学显著改善。治疗前,需要手术的潜水员报告的症状明显多于接受保守治疗的潜水员。治疗后,手术组和非手术组之间没有显著差异。总体而言,尽管仍发生 PSB,但 35 名潜水员在治疗后仍能成功恢复潜水,且无并发症。有鼻窦问题的潜水员可以成功地接受医学治疗,如果保守治疗失败,FESS 显示出症状有统计学显著改善,并且对潜水没有严重的长期危害。